Evidence map›Paper›PMID 40650764›Full record

ArticleVirchows Archiv : an international journal of pathology2026

An epithelioid hemangioendothelioma with a novel RREB1::TFE3 gene fusion.

Thomas Schumacher, Baptiste Ameline, Alexander Vogetseder, Beata Bode, Teodor Svantesson

Abstract readCase Reports
In one paragraph

Article in Virchows Archiv : an international journal of pathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Thomas SchumacherDepartment of Pathology, Cantonal Hospital Lucerne, Lucerne, Switzerland. thomas.schumacher@luks.ch.ORCID http://orcid.org/0009-0009-4013-7953
Baptiste AmelineInstitute for Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland.
Alexander VogetsederDepartment of Pathology, Cantonal Hospital Lucerne, Lucerne, Switzerland.
Beata BodeDepartment of Pathology, Cantonal Hospital Lucerne, Lucerne, Switzerland.
Teodor SvantessonDepartment of Pathology, Cantonal Hospital Lucerne, Lucerne, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epithelioid hemangioendothelioma (EHE) is a rare vascular tumor of intermediate malignant potential. Most cases are characterized by a WWTR1::CAMTA1 gene fusion, with YAP1::TFE3 being the second most common. We present a case of EHE in a 78-year-old woman with an RREB1::TFE3 gene fusion, which, to our knowledge, has not previously been described. The tumor was detected incidentally as a subpectoral soft tissue mass during imaging for a simultaneously diagnosed metastatic pulmonary adenocarcinoma. Aside from this, the patient's presentation was consistent with common clinical findings in EHE. Histologically, however, the tumor partly revealed an uncommon morphology: on one hand, solid areas of monomorphic epithelioid tumor cells with abundant eosinophilic cytoplasm, and on the other, regions with considerable and unusual pleomorphism and multinucleation, thus not clearly aligning with the prototypical phenotypes of the classical molecular subtypes. In summary, this case expands the molecular spectrum of EHE and supports further investigation into its molecular heterogeneity.

Indexed as

Basic Helix-Loop-Helix Leucine Zipper Transcription FactorsBiomarkers, TumorGene FusionHemangioendothelioma, EpithelioidLung NeoplasmsAgedFemaleHumansBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsBiomarkers, TumorTFE3 protein, humanEpithelioid hemangioendotheliomaNovel gene fusionRREB1Soft tissueTFE3

Identifiers

PMID40650764
PMCPMC13053504

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.